The 36-month beta value for AZTR is also noteworthy at -1.74. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 1 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for AZTR is 17.09M, and at present, short sellers hold a 6.65% of that float. The average trading volume of AZTR on June 17, 2025 was 1.45M shares.
AZTR) stock’s latest price update
The stock price of Azitra Inc (AMEX: AZTR) has jumped by 2.86 compared to previous close of 0.27. Despite this, the company has seen a fall of -7.60% in its stock price over the last five trading days. prnewswire.com reported 2025-06-17 that Drug candidate ATR12-351 has been generally safe and well-tolerated with occasional, transient, mild to moderate symptoms at application site Trial is 50% enrolled; six patients have received ATR12-351, a live precision dermatology therapeutic candidate Azitra presenting at the 2025 BIO International Convention BRANFORD, Conn., June 17, 2025 /PRNewswire/ — Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced encouraging safety data from the initial clinical trial of its live biotherapeutic candidate, ATR12-351, targeting Netherton syndrome.
AZTR’s Market Performance
AZTR’s stock has fallen by -7.60% in the past week, with a monthly rise of 2.67% and a quarterly drop of -19.62%. The volatility ratio for the week is 5.44% while the volatility levels for the last 30 days are 3.62% for Azitra Inc The simple moving average for the last 20 days is -1.29% for AZTR’s stock, with a simple moving average of -30.78% for the last 200 days.
AZTR Trading at -3.97% from the 50-Day Moving Average
After a stumble in the market that brought AZTR to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -97.69% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at AZTR starting from KDT VENTURES FUND I, LP, who proposed sale 9,730 shares at the price of $0.58 back on Sep 13 ’24. After this action, KDT VENTURES FUND I, LP now owns shares of Azitra Inc, valued at $5,648 using the latest closing price.
Stock Fundamentals for AZTR
Current profitability levels for the company are sitting at:
- -1877.66 for the present operating margin
- 1.02 for the gross margin
The net margin for Azitra Inc stands at -409.92. The total capital return value is set at -3.04. Equity return is now at value -208.50, with -152.02 for asset returns.
Based on Azitra Inc (AZTR), the company’s capital structure generated 0.1 points at debt to capital in total, while cash flow to debt ratio is standing at -6.5. The debt to equity ratio resting at 0.11. The interest coverage ratio of the stock is 10986.82.
Currently, EBITDA for the company is -10.99 billion with net debt to EBITDA at 0.19. When we switch over and look at the enterprise to sales, we see a ratio of -363.74. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.02.
Conclusion
In summary, Azitra Inc (AZTR) has had a bad performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
